← Back to Search

Dementia Home Care Intervention for Dementia

N/A
Recruiting
Led By Bruce Leff, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (6 months)
Awards & highlights

Study Summary

This trial will develop an intervention to improve care for people living with dementia and their caregivers in home-based primary care practices.

Who is the study for?
This trial is for adult caregivers living in the U.S. who provide at least 4 hours of daily care to someone with Alzheimer's or related dementias and are experiencing stress. Participants must speak English and expect to continue caregiving for the next 6 months. Staff participants should be part of a home-based primary care program.Check my eligibility
What is being tested?
The study aims to develop 'Dementia Care Quality at Home' for those with dementia and their caregivers, assessing its feasibility, acceptability, and fidelity within home-based primary care practices through an open-pilot trial involving trained clinicians.See study design
What are the potential side effects?
Since this intervention focuses on caregiver support rather than medical treatment, traditional side effects are not applicable. However, there may be emotional or psychological impacts from participating in focus groups or implementing new care strategies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility for the caregiver to access educational materials and community resources.
Feasibility for the caregiver to engage with and complete baseline assessments.
Feasibility for the practice of assessing eligible patient/caregiver dyads.
+2 more
Other outcome measures
Acceptability of the intervention to caregivers and patient to participate in the intervention.
Caregiver well-being
Feasibility for the practice of clinicians to engage with the tele-video case conference.
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dementia Care Quality at HomeExperimental Treatment1 Intervention
Each HBPC practice will receive the Dementia Care Quality at Home intervention.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,935 Previous Clinical Trials
13,198,543 Total Patients Enrolled
25 Trials studying Dementia
202,475 Patients Enrolled for Dementia
Retirement Research FoundationOTHER
9 Previous Clinical Trials
1,686 Total Patients Enrolled
1 Trials studying Dementia
50 Patients Enrolled for Dementia
Bruce Leff, MDPrincipal InvestigatorJohns Hopkins University

Media Library

Dementia Care Quality at Home Clinical Trial Eligibility Overview. Trial Name: NCT05849259 — N/A
Dementia Research Study Groups: Dementia Care Quality at Home
Dementia Clinical Trial 2023: Dementia Care Quality at Home Highlights & Side Effects. Trial Name: NCT05849259 — N/A
Dementia Care Quality at Home 2023 Treatment Timeline for Medical Study. Trial Name: NCT05849259 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for potential participants in this experiment?

"According to the clinicaltrials.gov report, this medical study is no longer recruiting individuals. This trial was released on May 1st 2023 and last edited on May 5th 2023; nonetheless, there are 658 other studies actively looking for patients right now."

Answered by AI
Recent research and studies
~24 spots leftby Jul 2024